Nexavar | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nexavar
FDA Orange Book

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Nexavar

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 20 USDMF, 2 CEP/COS, 1 JDMF, 11 EU WC, 8 KDMF, 10 NDC API, 41 Listed Suppliers, $ API Reference Price

58 API Suppliers
20 USDMF
2 CEP/COS
1 JDMF
11 EU WC
8 KDMF
10 NDC API
41 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

17 Intermediates Suppliers

17 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 6 FDA Orange Book, 7 Europe, 1 Canada, 3 Australia, 2 South Africa, 11 Listed Dossiers

30 FDF Dossiers
6 FDA Orange Book
7 Europe
1 Canada
3 Australia
2 South Africa
11 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 2 DKSH, 1 Jai Radhe Sales, 7 Gangwal Healthcare, 1 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 25 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 16 Direct Compression, 15 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 13 Granulation, 12 Lubricants & Glidants, 8 Co-Processed Excipients, 8 Topical, 7 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 5 Solubilizers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Rheology Modifiers, 2 Parenteral, 2 Emulsifying Agents, 1 Surfactant & Foaming Agents

45 Coating Systems & Additives
25 Fillers, Diluents & Binders
25 Controlled & Modified Release
16 Direct Compression
15 Disintegrants & Superdisintegrants
15 Thickeners and Stabilizers
13 Granulation
12 Lubricants & Glidants
8 Co-Processed Excipients
8 Topical
7 Film Formers & Plasticizers
6 Taste Masking
5 Empty Capsules
5 Solubilizers
4 Vegetarian Capsules
4 Coloring Agents
3 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Rheology Modifiers
2 Parenteral
2 Emulsifying Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 103 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
103 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 5 Finished Drug Prices, 9 Annual Reports

2 US Medicaid Prescriptions
5 Finished Drug Prices
9 Annual Reports

MARKET PLACE

8 APIs, 11 FDF Dossiers

8 APIs
11 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 9 Health Canada Patents

4 US Patents
9 Health Canada Patents

REF. STANDARDS & IMPURITIES

13 Others

13 Others

$ API Ref.Price (USD/KG) : 4,355 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 1DR REDDYS

02 1BAYER HLTHCARE

03 1MYLAN

04 1TEVA PHARMS USA INC

05 1TORRENT

06 1YABAO PHARM

filter Dosage Reset all filters

6 All

01 6TABLET;ORAL

filter Regulatory Info Reset all filters

6 All

01 6RX

filter Brand Name Reset all filters

6 All

01 1NEXAVAR

02 5SORAFENIB TOSYLATE

filter RLD Reset all filters

6 All

01 5No

02 1Yes

List of Suppliers

Product Main Page

01

DR REDDYS

CPhI India 2024

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

Digital Content

RLD : No

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : SORAFENIB TOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2022-06-07

Application Number : 216073

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

Product Web Link

Digital Content

02

BAYER HLTHCARE

2024 ACI Convention

Not Confirmed

BAYER HLTHCARE

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : NEXAVAR

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2005-12-20

Application Number : 21923

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TEVA PHARMS USA INC

2024 ACI Convention

Not Confirmed

TEVA PHARMS USA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : SORAFENIB TOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2020-11-12

Application Number : 209567

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TORRENT

2024 ACI Convention

Not Confirmed

TORRENT

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : SORAFENIB TOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2023-04-12

Application Number : 217095

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MYLAN

2024 ACI Convention

Not Confirmed

MYLAN

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : SORAFENIB TOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2020-09-10

Application Number : 207012

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

YABAO PHARM

2024 ACI Convention

Not Confirmed

YABAO PHARM

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

SORAFENIB TOSYLATE

Brand Name : SORAFENIB TOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Approval Date : 2022-11-09

Application Number : 209050

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?